Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case
The US government filed an amicus brief in a Louisiana federal 340B case siding with pharmaceutical manufacturers, arguing states cannot enforce 340B contract pharmacy protections. Combined with a Fourth Circuit ruling blocking West Virginia's 340B law, this signals coordinated erosion of state-level 340B protections that could cost CA FQHCs millions in drug discount revenue.
Primary source
National Law ReviewSource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
FQHC Talent. (2026, April 4). Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case. Primary source: National Law Review. Retrieved July 28, 2026, from https://www.fqhctalent.com/intel/us-amicus-brief-pharma-louisiana-340b
More in Legislation
Jul 24
HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee
Jul 22
Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge